SA
ALPMY logo
Astellas Pharma Inc.(ALPMY)
Closing price · checked 10:13 PM ETAbout this dataData status
$16.96▲0.06 (0.36%)
Extended:$16.96+0.00 (+0.00%)· 10:13 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 24.6)

Overview →

Astellas Pharma Inc. (ALPMY)

R&D to Revenue

14.72%

Fiscal year · Period ending:

ALPMY logo

ALPMY R&D to Revenue

Latest reported14.72%
ALPMY FY R&D/Revenue (0.00% → 14.72%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

ALPMY r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Astellas Pharma Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
14.7167%
17.1362%
18.3454%
18.181%
18.9791%
17.9668%
17.235%
15.9758%
16.9805%
15.8653%
16.442%
16.5643%
16.7996%
18.094%
0%
0%
20.061%
16.4708%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.